Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have at least one recorded diagnosis code for Alzheimer's disease (AD) from a hospital stay, or at least two recorded diagnosis codes for AD from outpatient visits that were at least 7 days apart but less than 365 days apart, on or before a key reference date used in the study.
- People who have had continuous health insurance coverage — including both medical and pharmacy benefits — for at least 365 days before that key reference date.
- People who have electronic health record (EHR) data available either on the key reference date, or from within 30 days before to 90 days after that date.
- People who have written clinical notes in their electronic health records from at least one healthcare visit, either on the key reference date or within the period of 30 days before to 45 days after that date.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- For the part of the study looking at new-onset seizures only: people who have any recorded diagnosis code for a seizure or epilepsy before the key reference date used in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1-888-274-2378
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Positive Predictive Value (PPV) of algorithms to identify intracerebral hemorrhage >1 cm in diameter
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.